, Volume 46, Issue 2, pp 197–206 | Cite as

Alveolar echinococcosis in Germany, 1992–2016. An update based on the newly established national AE database

  • Julian Schmidberger
  • Wolfgang Kratzer
  • Klaus Stark
  • Beate Grüner
  • For the Echinococcosis Working Group
Original Paper



Alveolar echinococcosis is a rare disease caused by the parasite Echinococcus multilocularis. The newly established national database should enable us to determine high-risk areas and evaluate the endemic levels.


The national database was implemented using SQL Workbench. We used EpiInfo™ software to display the prevalence of disease. Moran’s I geodata analysis according to cluster and high risk areas was performed with GeoDa™. SAS Version 9.2 was used for the statistical analysis of the cases (n = 523).


The analysis showed a concentration of cases in Baden-Württemberg and Bavaria. Moran’s I showed a heterogeneous case distribution throughout Germany (I = 0.208815, Z = 32.6175, p < 0.001). In the period from 1992 to 2016, the prevalence was 0.64/100,000 inhabitants in the whole of Germany, 2.18/100,000 inhabitants in Baden-Württemberg and 1.48/100,000 inhabitants in Bavaria. The analysis also revealed a difference between men and women, with a prevalence of 0.58/100,000 and 0.69/100,000, respectively. The analysis of spatial autocorrelation and possible risk areas showed that the southeast regions of Baden-Württemberg (I = 0.188514, Z = 11.3197, p < 0.001) and the southwest part of Bavaria (I = 0.176953, Z = 13.5144, p < 0.001) constitute the high risk areas.


The prevalence of disease is noticeably high in the Swabian Jura, the Bavarian Alps and the Alpine foothills. Raising awareness and educating doctors in high risk areas may prevent new cases and assist in earlier diagnosis.


Alveolar echinococcosis Echinococcus multilocularis Prevalence Distribution National database 



Members of the Echinococcosis Working Group: Thomas FE Barth, Sven Baumann, Ambros Beer, Doris Henne-Bruns, Tilmann Gräter, Andreas Hillenbrand‚ Peter Kern, Petra Kern, Tanja Kaltenbach, Rainer Muche.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.


The work presented here is based on a dissertation and contains some parts of it.

Ethical standards

The study was approved by the University of Ulm Ethics Committee approval and the Declaration of Helsinki (ref. No. 440/15).

Financial support

The newly established national database for alveolar echinococcosis is a project sponsored by the German Research Foundation (DFG) (ref. no. 440/15).


  1. 1.
    Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, Vuitton DA, Kern P. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis. 2003;9:343–9.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Deplazes P, Rinaldi L, Alvarez Rojas CA, Torgerson PR, Harandi MF, Romig T, Antolova D, Schurer JM, Lahmar S, Cringoli G, Magambo J, Thompson RC, Jenkins EJ. Global distribution of alveolar and cystic echinococcosis. Adv Parasitol. 2017;95:315–493.CrossRefPubMedGoogle Scholar
  3. 3.
    Torgerson PR, Keller K, Magnotta M, Ragland N. The global burden of alveolar echinococcosis. PLoS Negl Trop Dis. 2010;4:e722.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Craig PS, Deshan L, MacPherson CN, Dazhong S, Reynolds D, Barnish G, Gottstein B, Zhirong W. A large focus of alveolar echinococcosis in central China. Lancet. 1992;340:826–31.CrossRefPubMedGoogle Scholar
  5. 5.
    Zhang W, Zhang Z, Wu W, Shi B, Li J, Zhou X, Wen H, McManus DP. Epidemiology and control of echinococcosis in central Asia, with particular reference to the People’s Republic of China. Acta Trop. 2015;141:235–43.CrossRefPubMedGoogle Scholar
  6. 6.
    Craig PS. Epidemiology of human alveolar echinococcosis in China. Parasitol Int. 2006;55:221–5.CrossRefGoogle Scholar
  7. 7.
    Romig T, Kratzer W, Kimmig P, Frosch M, Gaus W, Flegel WA, Gottstein B, Lucius R, Beckh K, Kern P. An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. Römerstein Study Group. Am J Trop Med Hyg. 1999;61:566–73.CrossRefPubMedGoogle Scholar
  8. 8.
    Ammann RW, Eckert J. Cestodes. Echinococcus. Gastroenterol Clin North Am. 1996;25:655–89.CrossRefPubMedGoogle Scholar
  9. 9.
    Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev. 2004;17:107–35.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kern P, Ammon A, Kron M, Sinn G, Sander S, Petersen LR, Gaus W, Kern P. Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis. 2004;10:2088–93.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Piarroux M, Piarroux R, Knapp J, Bardonnet K, Dumortier J, Watelet J, Gerard A, Beytout J, Abergel A, Bresson-Hadni S, Gaudart J. Populations at risk for alveolar echinococcosis. France. Emerg Infect Dis. 2013;19:721–8.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Kreidl P, Allerberger F, Judmaier G, Auer H, Aspöck H, Hall AJ. Domestic pets as risk factors for alveolar hydatid disease in Austria. Am J Epidemiol. 1998;147:978–81.CrossRefPubMedGoogle Scholar
  13. 13.
    Lass A, Szostakowska B, Myjak P, Korzeniewski K. Fresh fruits, vegetables and mushrooms as transmission vehicles for Echinococcus multilocularis in highly endemic areas of Poland: reply to concerns. Parasitol Res. 2016;115:3637–42.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Bresson-Hadni S, Laplante JJ, Lenys D, Rohmer P, Gottstein B, Jacquier P, Mercet P, Meyer JP, Miguet JP, Vuitton DA. Seroepidemiologic screening of Echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis. Am J Trop Med Hyg. 1994;51:837–46.CrossRefPubMedGoogle Scholar
  15. 15.
    Reuter S, Buck A, Manfras B, Kratzer W, Seitz HM, Darge K, Reske SN, Kern P. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology. 2004;39:509–17.CrossRefPubMedGoogle Scholar
  16. 16.
    Nunnari G, Pinzone MR, Gruttadauria S, Celesia BM, Madeddu G, Malaguarnera G, Pavone P, Cappellani A, Cacopardo B. Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol. 2012;18:1448–58.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Reuter S, Nüssle K, Kolokythas O, Haug U, Rieber A, Kern P, Kratzer W. Alveolar liver echinococcosis: a comparative study of three imaging techniques. Infection. 2001;29:119–25.CrossRefPubMedGoogle Scholar
  18. 18.
    Reuter S, Grüner B, Buck AK, Blumstein N, Kern P, Reske SN. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET. Nuklearmedizin. 2008;47:147–52.PubMedGoogle Scholar
  19. 19.
    Bresson-Hadni S, Delabrousse E, Blagosklonov O, Bartholomot B, Koch S, Miguet J-P, Mantion GA, Vuitton DA. Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis. Parasitol Int. 2006;55:267–72.CrossRefGoogle Scholar
  20. 20.
    Bresson-Hadni S, Delabrousse E, Grenouillet F, Mantion G, Vuitton D-A. Alveolar echinococcosis: how to confirm the diagnosis? Bull Acad Natl Med. 2008;192:1141–50.PubMedGoogle Scholar
  21. 21.
    Siles-Lucas M, Casulli A, Conraths FJ, Müller N. Laboratory diagnosis of Echinococcus spp. in human patients and infected animals. Adv Parasitol. 2017;96:159–257.CrossRefPubMedGoogle Scholar
  22. 22.
    Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114:1–16.CrossRefPubMedGoogle Scholar
  23. 23.
    Barth TFE, Herrmann TS, Tappe D, Stark L, Gruner B, Buttenschoen K, Hillenbrand A, Juchems M, Henne-Bruns D, Kern P, Seitz HM, Moller P, Rausch RL, Kern P, Deplazes P. Sensitive and specific immunohistochemical diagnosis of human alveolar echinococcosis with the monoclonal antibody Em2G11. PLoS Negl Trop Dis. 2012;6:e1877.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Siles-Lucas MM, Gottstein BB. Molecular tools for the diagnosis of cystic and alveolar echinococcosis. Trop Med Int Health. 2001;6:463–75.CrossRefPubMedGoogle Scholar
  25. 25.
    Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother. 2000;46:451–6.CrossRefPubMedGoogle Scholar
  26. 26.
    Jorgensen P, An der Heiden M, Kern P, Schöneberg I, Krause G, Alpers K. Underreporting of human alveolar echinococcosis, Germany. Emerg Infect Dis. 2008;14:935–7.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Gruener B, Kern P, Mayer B, Graeter T, Hillenbrand A, Barth TEF, Muche R, Henne-Bruns D, Kratzer W, Kern P. Comprehensive diagnosis and treatment of alveolar echinococcosis: a single-center, long-term observational study of 312 patients in Germany. GMS Infect Dis. 2017;5:Doc01.Google Scholar
  28. 28.
    Anselin L. Local Indicators of Spatial Association-LISA. Geogr Anal. 1995;27:93–115.CrossRefGoogle Scholar
  29. 29.
    Charbonnier A, Knapp J, Demonmerot F, Bresson-Hadni S, Raoul F, Grenouillet F, Millon L, Vuitton DA, Damy S. A new data management system for the French National Registry of human alveolar echinococcosis cases. Parasite. 2014;21:69.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Nationales Aktionsbündnis für Menschen mit Seltenen Erkrankungen. Nationaler Aktionsplan für Menschen mit Seltenen Erkrankungen: Handlungsfelder, Empfehlungen und Maßnahmenvorschläge (2013). Accessed 12 Oct 2017.
  31. 31.
    Tamarozzi F, Rossi P, Galati F, Mariconti M, Nicoletti GJ, Rinaldi F, Casulli A, Pozio E, Brunetti E. The Italian registry of cystic echinococcosis (RIEC): the first prospective registry with a European future. Euro Surveill. 2015;20:21115.CrossRefPubMedGoogle Scholar
  32. 32.
    Schweiger A, Ammann RW, Candinas D, Clavien PA, Eckert J, Gottstein B, Halkic N, Muellhaupt B, Prinz BM, Reichen J, Tarr PE, Torgerson PR, Deplazes P. Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis. 2007;13:878–82.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Vuitton DA, Demonmerot F, Knapp J, Richou C, Grenouillet F, Chauchet A, Vuitton L, Bresson-Hadni S, Millon L. Clinical epidemiology of human AE in Europe. Vet Parasitol. 2015;213:110–20.CrossRefPubMedGoogle Scholar
  34. 34.
    Piarroux M, Gaudart J, Bresson-Hadni S, Bardonnet K, Faucher B, Grenouillet F, Knapp J, Dumortier J, Watelet J, Gerard A, Beytout J, Abergel A, Wallon M, Vuitton DA, Piarroux R. Landscape and climatic characteristics associated with human alveolar echinococcosis in France, 1982–2007. Euro Surveill. 2015;20:1–10.CrossRefGoogle Scholar
  35. 35.
    Pleydell DRJ, Yang YR, Danson FM, Raoul F, Craig PS, McManus DP, Vuitton DA, Wang Q, Giraudoux P. Landscape composition and spatial prediction of alveolar echinococcosis in southern Ningxia, China. PLoS Negl Trop Dis. 2008;2:287–97.CrossRefGoogle Scholar
  36. 36.
    Craig PS, Hegglin D, Lightowlers MW, Torgerson PR, Wang Q. Echinococcosis: control and prevention. Adv Parasitol. 2017;96:55–158.CrossRefPubMedGoogle Scholar
  37. 37.
    Haenle MM, Brockmann SO, Kron M, Bertling U, Mason RA, Steinbach G, Boehm BO, Koenig W, Kern P, Piechotowski I, Kratzer W. Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults. BMC Public Health. 2006;6:233–45.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Nothdurft HD, Jelinek T, Mai A, Sigl B, von Sonnenburg F, Löscher T. Epidemiology of alveolar echinococcosis in southern Germany (Bavaria). Infection. 1995;23:85–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Wang Q, Qin J, Yang W, Schantz PM, Raoul F, Craig PS, Giraudoux P, Vuitton DA. Socioeconomic and behavior risk factors of human alveolar echinococcosis in Tibetan communities in Sichuan, People’s Republic of China. Am J Trop Med Hyg. 2006;74:856–62.PubMedGoogle Scholar
  40. 40.
    Besag J, Newell J. The detection of clusters in rare diseases. J R Stat Soc Ser A. 1991;154:143–55.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  1. 1.Central Ultrasound, Department of General Internal Medicine I, Medical CentreUniversity Hospital UlmUlmGermany
  2. 2.Comprehensive Infectious Diseases Centre, Department of General Internal Medicine III, Medical CentreUniversity Hospital UlmUlmGermany
  3. 3.Department of Infectious Disease EpidemiologyRobert Koch InstituteBerlinGermany

Personalised recommendations